A Prospective, Open-label, Multicenter Extension Study on the Efficacy and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in Heart Transplant Recipients
A Prospective, Open-label, Multicenter Extension Study on the Efficacy and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in Heart Transplant Recipients
This purpose of this extension study of patients being treated with EC-MPS is to assess the long term safety of this medication.
Inclusion Criteria:
Patients who were participating in the core study CERL080A2401 and have successfully completed the first 12 months of the core study
Exclusion Criteria:
Patients who did not complete the 12-month core study CERL080A2401
Other protocol-defined inclusion/exclusion criteria may apply.